Hemovigilance Program-India

Abstract

A centralized hemovigilance program to assure patient safety and to promote public health has been launched for the first time in India on Dec 10, 2012 in 60 medical colleges in the first phase along with a well-structured program for monitoring adverse reactions associated with blood transfusion and blood product administration. National Institute of Biologicals (NIB) will be the National Coordinating Centre for Hemovigilance. This program will be implemented under overall ambit of Pharmacovigilance Program of India (PvPI), which is being coordinated by Indian Pharmacopoeia Commission (IPC). All medical colleges of the country will be enrolled in this program by the year 2016 in order to have a National Centre of Excellence for Hemovigilance at NIB, which will act as a global knowledge platform.

Non Infectious Complications Related to Blood Transfusion: An 11 year Retrospective Analysis in a Tertiary Care Hospital

“…The Hemovigilance Program of India which finds its roots from the European Hemovigilance network, being launched in 2012 is still in its infancy [3]. A lot needs to be done to achieve the ultimate goal of being a part of the International Hemovigilance Network.…”

A study of transfusion related adverse events at a tertiary care centre in North India: an initiative towards hemovigilance

“…The main objectives of the programme are to track adverse reactions/events and incidence associated with transfusion of blood and blood product and to help identify trends, recommends best practices and interventions required to improve patient care and safety, while improving the overall health care. 3 Sixty medical colleges will be enrolled in it including Government Medical College, Jammu. The present study was undertaken to detect and analyze the transfusion related adverse events as a pilot effort towards hemovigilance from the institution.…”

Seroprevalence of transfusion-transmissible infectious agents (HIV, HBV, HCV, plasmodium species and treponema pallidum infections) among blood donors at a Tertiary Care Teaching Hospital in Chennai: Changing trends over a period of five years

“…5 Among the Asian countries, a well established hemovigilance system is lacking and there is paucity of data on hemovigilance except for Japan, which has published report on adverse transfusion reactions and infectious diseases. 6,7 Viral infections such as HIV, HBV and HCV cause big anxiety due to protracted viraemia along with carrier / latent state.…”